Discover 486 paid clinical trials in Warwick, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 486
FeaturedActive & Responsive
Type 2 Diabetes Studies on Blood Sugar and Weight Management for Adults Not on Insulin
for
Diabetes Mellitus, Type 2, Obesity
Location: East Greenwich RI, Binghamton NY, East Syracuse NY,
Sex: All
Age: 18 - 70+
Recruiting
FeaturedActive & Responsive
Weight Loss Studies for Adults With a BMI of 27+, Including People Managing Type 2 Diabetes or Sleep Apnea
for
Obesity, Overweight, Diabetes Mellitus, Type 2,
Location: East Greenwich RI, Binghamton NY, East Syracuse NY,
Sex: All
Age: 18+
Recruiting
FeaturedActive & Responsive
Migraine Prevention Studies for Adults With 2–10 Moderate-to-Severe Attacks a Month
for
Migraine Disorders
Location: East Greenwich RI, Beachwood OH, Cincinnati OH,
Sex: All
Age: 18 - 70+
Recruiting
FeaturedActive & Responsive
Fatty Liver Disease (MASH/NASH) Studies for Adults Also Managing Diabetes, High Blood Pressure, or High Cholesterol
for
Non-alcoholic Fatty Liver Disease
Location: East Greenwich RI, Dallas TX, Waco TX, Albuquerque NM,
Sex: All
Age: 18 - 70+
Recruiting
FeaturedActive & Responsive
Diabetic Nerve Pain Study of a Non-Opioid Medication for Adults With Ongoing Foot and Leg Pain
for
Diabetic Neuropathies
Location: East Greenwich RI, East Syracuse NY, Washington DC,
Sex: All
Age: 18 - 70+
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: East Greenwich RI, Boston MA, Waterbury CT,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT07231419
Phase 3, Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: East Greenwich RI, Boston MA, Waltham MA, New York NY,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT06628908
Phase 3, Recruiting
Active & Responsive
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
for
Obesity, Overweight
Location: East Greenwich RI, Waterbury CT, Binghamton NY,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07684235
Phase 3, Recruiting
Active & Responsive
A Study of V132 in Healthy Older Participants (V132-001)
for
Healthy
Location: East Greenwich RI, Columbus OH, Hollywood FL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 50 - 70+
Code: NCT07712575
Phase 1, Recruiting
Active & Responsive
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
for
Obesity, Overweight, Diabetes Mellitus, Type 2
Location: East Greenwich RI, Trenton NJ, Annapolis MD, Burke VA,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07684144
Phase 3, Recruiting
Active & Responsive
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
for
Menstrual Migraine
Location: East Greenwich RI, The Bronx NY, Philadelphia PA,
Sponsor: Pfizer
Sex: Female
Age: 18 - 45
Code: NCT06641466
Phase 3, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Providence RI, New York NY, Montreal, Glen Burnie MD,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT06233461
Phase 2, Recruiting
Active & Responsive
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
for
Alzheimer Disease
Location: Providence RI, North Dartmouth MA, Boston MA,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All
Age: 55 - 70+
Code: NCT06585787
Phase 3, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer